Objectives/Hypothesis: Otitis media is a common problem in the pediatric population. Despite antibiotic therapy, posttympanostomy otorrhea can be difficult to treat. Biofilms have been shown to play a role in chronic and recurrent otitis media and are implicated in otorrhea. This study investigated both the microbial composition and the presence of biofilm fragments rich in extracellular DNA (eDNA) and the bacterial DNA-binding protein, integration host factor (IHF), in post-tympanostomy tube otorrhea.
INTRODUCTION
Otitis media with effusion and recurrent acute otitis media are common problems in children, with a cumulative incidence of up to 80% by the age of 4 years. 1 Treatment of otitis media has consisted of systemic antibiotics, and surgical placement of tympanostomy tubes is performed for those resistant to medical treatment. Tympanostomy tubes are placed in 667 thousand children younger than 15 years every year, making this the most common ambulatory surgery performed on children in the United States. 2 Tympanostomy tubes do not typically prevent otitis media, but can relieve symptoms such as conductive hearing loss and pain associated with infection. Patients with tympanostomy tubes are treated with topical antibiotics and steroids, alleviating the need for a systemic antibiotic. However, complications associated with ear tube placement include tympanic membrane perforation, occurring in 1% to 2% of patients, extrusion, tympanosclerosis, and post-tympanostomy tube otorrhea. 3 Post-tympanostomy tube otorrhea can lead to tube occlusion and discomfort and can be described as acute, lasting less than 6 to 8 weeks, or chronic, lasting greater than 6 to 8 weeks. 4 The proportion of children who have experienced post-tympanostomy tube otorrhea has been cited as reaching 74% within 12 months and can be difficult to treat. Failure of topical antibiotic therapy and persistent otorrhea may lead to the additional use of oral antibiotic therapy and possibly tympanostomy tube removal. [5] [6] [7] [8] Culture results from post-tympanostomy tube otorrhea has implicated common microorganisms associated with acute otitis media, including nontypeable Haemophilus influenzae (NTHI), Streptococcus pneumoniae, and Moraxella catarrhalis. [9] [10] [11] In addition, Staphylococcus aureus and Pseudomonas aeruginosa are other bacteria implicated in chronic otorrhea and are likely to have entered into the middle ear via the auditory canal through the tympanostomy tube. 12 The formation of biofilms within the middle ear and in association with tympanostomy tubes have been investigated as a possible source for chronic otitis media and posttube insertion otorrhea. Hall-Stoodley et al. were able to identify biofilms in association with middle ear mucosal biopsies within a pediatric population suffering from chronic otitis media. Generic stains and specific probes identified NTHI, S. pneumoniae, and M. catarrhalis, thus correlating these predominant otopathogens with biofilm formation. 11 Furthermore, in an effort to decrease the incidence of post-tympanostomy tube otorrhea, numerous studies have been dedicated to identifying strategies to either transform the composition of the tube or the coating of the tube in order to inhibit biofilm growth. Although multiple variables have been altered, there has not been a consensus as to which modification may provide the most benefit to this surgical treatment modality. [12] [13] [14] [15] [16] [17] Although research has shown that biofilms are present on middle ear mucosal surfaces and on tympanostomy tubes, there continues to be an increased incidence of post-tympanostomy tube otorrhea, despite tailoring medical regimen and tympanostomy tube alterations to the presence of these specific microbes. We theorize that multiple physical and biological properties of the biofilms produced by these bacteria make them resistant to these various treatment modalities. Supporting this assertion is the fact that bacteria residing within a biofilm are known to be 1,000-fold more resistant to standard antibiotic treatment compared to planktonic bacteria. 18 The foundation of biofilm communities is the extracellular polymeric substance (EPS) or matrix, which is involved in facilitating adhesion to surfaces and provides a physical barrier that protects the bacterial cells that reside within the biofilm. The arrangement of the EPS is highly diverse; however, the EPS of many human pathogens contains a large amount of extracellular DNA (eDNA) of both bacterial and host origin. The eDNA derived from bacteria is found in association with a family of bacterial DNABII-binding proteins, one of which has been identified at integration host factor (IHF), which has been confirmed as an essential structural support for extracellular DNA in bacterial biofilms. [19] [20] [21] Targeting these proteins via use of antibodies directed against them results in catastrophic collapse of the biofilm structure with release of the resident bacteria, as mediated by an equilibrium shift as DNABII proteins are titrated away from the biofilm. 19, 22 Furthermore, there is a known synergistic effect between anti-IHF antibodies and traditional antibiotic treatment, wherein bacteria newly released from the biofilm matrix in this manner are 4-to 8-fold more sensitive to the killing action of several first-line antibiotics for treatment of otitis media, which are ineffective on their own against bacteria residing within a biofilm. 19 The ability of anti-IHF antibodies to weaken the structural support of the biofilm matrix increases the efficacy of antibiotics and immune modulators to the resident bacterial cells, thus enhancing clearance of the biofilm. 19 To effectively devise a novel strategy to combat post-tympanostomy tube-insertion-associated otorrhea will require a clearer understanding of the microbiological basis for the extended drainage of fluids from the middle ear space. The basis of this investigation is grounded in the fact that biofilms continue to provide structural support and resistance to resident pathogens, despite attempts to customize antibiotic therapy and modify tube structure and composition in an attempt to eradicate these biofilms. Because tympanostomy tube insertion continues to be one of the most common surgical interventions for the pediatric population, targeting the actual components that confer stability to the biofilm matrix may prove to be an optimal treatment modality. Toward this goal, we first needed to determine if posttympanostomy tube otorrhea samples contained bacterial biofilms, and if these biofilms would contain both a lattice of crossed strands of eDNA as well as an associated DNABII protein (e.g., IHF) positioned at the vertices of these crossed eDNA strands, as we have shown in several other disease models. 19, 21, 23, 24 Microbiological cultures were also obtained from specimens to correlate the presence of specific pathogens with that of biofilm fragments contained within otorrhea samples that fulfilled the aforementioned criteria.
MATERIALS AND METHODS

Post-tympanostomy Tube Otorrhea Collection
Institutional review board approval was obtained, and pediatric population with tympanostomy tubes and persistent otorrhea were identified in the pediatric otolaryngology clinic. Samples were collected through the tympanostomy tube via a sterile Juhn Tymp-Tap Middle Ear Fluid Aspirator/Collector (Medtronic Xomed Inc, Jacksonville, FL). Specimens were labeled according to laterality of collection, gender of the patient from which specimen was obtained, age of patient, color, and relative consistency of the sample collected. After completion of the collection, the remainder of the otorrhea exudate was cultured using sterile BBL Culture Swab Collection and Transportation System (Becton, Dickinson and Company, Sparks, MD) and was sent to Nationwide Children's Hospital microbiology department for further speciation. The remainder of the specimen was removed from the collection tube and frozen in optimum cutting temperature (OCT) compound for immunohistochemical analysis.
Preparation of Sample and General Immunofluorescence Staining for Labeling IHF
The portion of the sample brought to the lab was embedded in OCT compound (Fisher Scientific, Pittsburgh, PA), snap frozen over liquid nitrogen, and stored at 2808C until further analysis. Ten micron serial sections were cut using a Microm Rotary Cryotome, adhered to glass slides (Mercedes Medical, Sarasota, FL), and stored at 2808C. Sections were later stained to determine the presence of both eDNA and DNABII proteins in the samples. Briefly, slides were air-dried, fixed in cold acetone, and then equilibrated in buffer (0.05 M Tris-HCl, 0.15 M NaCl, and 0.05% Tween 20, pH 7.4). Sections were blocked with Image-iT FX signal enhancer (Molecular Probes, Eugene, OR) and with Background Sniper (BioCare Medical, Concord, CA) as per manufacturer's instructions. Sections were then incubated with a 1:200 dilution of polyclonal rabbit anti-IHF E. coli overnight at 48C in a humidified chamber. Slides were rinsed and incubated with goat anti-rabbit IgG conjugated to Alexa eFluor 594 (Invitrogen, Eugene, OR) for 30 minutes at room temperature. As a counterstain for eDNA, sections were incubated with 4',6-diamidino-2-phenylindole (DAPI) and cover-slipped using ProLong Gold Anti-fade Reagent (Molecular Probes, Eugene, OR). Use of naive rabbit serum in place of immune serum and use of secondary antibody alone served as negative control preparations for immunolabeling studies. Sections were viewed with a Zeiss Axiovert 200M inverted microscope (Carl Zeiss Inc., Thornwood, NY).
Statistical Analysis
Not applicable.
RESULTS
A total of 15 samples were collected and processed for immunofluorescent labeling for the presence of a DNABII protein (e.g., IHF) and counterstained for eDNA (Table I) .
Culture Results
Of the 15 total specimens, 11 (73%) were culturepositive for bacterial species, whereas one yielded yeast. In four of 11 specimens that were culture-positive for bacterial species, one of the three predominant otopathogens of otitis media was cultured (e.g., NTHI, S. pneumoniae, and M. catarrhalis). Two additional cultures (15%) yielded methicillin-resistant S. aureus. The remaining specimens were of mixed microbial origin, whereas three specimens were culture-negative. The culture-negative specimens were noted to have solid fragments of cerumen, which is suspected to have antimicrobial properties that could inhibit bacterial growth. 25 However, this culture-negative status is the hallmark of middle ears that contain biofilms and thus was not unexpected. [26] [27] [28] Moreover, these children are typically treated with topical antibiotics that may have contributed to the culture-negative status of these latter three specimens. The positive labeling for a DNABII protein in association with a dense lattice of eDNA within solids present in otorrhea samples recovered from children post-tympanostomy tube insertion suggested the contribution of bacterial biofilms to this chronic condition. Of the 15 samples labeled with rabbit anti-IHF E.
coli and counterstained with DAPI, nine were positive for both eDNA and the DNA-binding protein IHF. Sixty percent of all specimens were positive for IHF, and as additional support for the hypothesis that bacterial biofilms might be contributing to the chronic otorrhea in these children, eight of the 11 (73%) samples that were positive for microbial growth were also positive for labeling with antibodies directed against the DNABII protein, IHF ( Figs. 1 and 2 ).
DISCUSSION
Most children have experienced at least one acute otitis media episode by the age of 3 years, and by 6 years at least 40% have experienced three or more episodes. 29 The socioeconomic burden of acute otitis media is significant. In 2011, mean expenditures per child with expenses to treat otitis media were $427 for the 7.5 million children treated. Simultaneously, the national expenditure for treatment and disability associated with otitis media exceeded $3.2 billion. 30, 31 For this reason, otitis media continues to draw attention in the research community.
Tympanostomy tube insertion is the primary surgical treatment for otitis media. Tympanostomy tubes were introduced in 1952 by Beverly Armstrong as a new treatment for chronic secretory otitis media. Since the introduction, there has been a multitude of variations on the material, size, and shapes of the tympanostomy tube. 32 Tympanostomy tube insertion continues to be the mainstay treatment for otitis media with effusion and Eustachian tube dysfunction, in which it has been associated with improved quality of life for both the child and care giver. A study by Boruk et al. published in Otolaryngology-Head Neck Surgery in 2007 showed that physical suffering during an episode of otitis media was a problem for 85% of children, emotional distress for 76%, and activity limitations for 57%. It was also notable because 31% of caregivers had to cancel family activities, 29% reported lack of sleep and 12% missed work or school. 33 The efficacy of tympanostomy tubes treating chronic otitis media with effusion, recurrent acute otitis media, or both have been studied in randomized control trials. Tympanostomy tube insertion decreases the prevalence of middle ear effusion in children suffering from chronic otitis media by 32% in the first year and improves average hearing level by 5 db to 12 db. 34, 35 The variations within the designs of tympanostomy tubes have sought to improve clinical efficacy through the ease of insertion into the tympanic membrane, duration of tube placement, decreased bacterial growth, and clearance of effusion. The difficulty in incorporating all of these variables is the reason that no single type of tympanostomy tube has gained widespread acceptance. Furthermore, there is no one type of tympanostomy tube in which bacteria will not adhere. 4 A major factor is that tympanostomy tubes and middle ear mucosa represent ideal environments for attachment of bacteria and biofilm growth. Bacteria and biofilms have been shown to adhere to natural and synthetic materials via the use of a self-produced matrix of extracellular polymeric substances (EPS) comprised of extracellular DNA, proteins, and polysaccharides. The EPS is a semipermeable layer that comprises approximately 90% of the biofilm mass. It selectively allows diffusion of water, nutrients, and essential substances through the matrix while protecting resident bacteria from exposure to antibiotics, host defense cells and soluble immune effectors, and other microorganisms. 20 These components allow the bacteria to have a 1,000-fold resistance to antibiotic therapies when compared to their planktonic form. 18 Bakaletz et al. demonstrated that nontypeable Haemophilus influenza biofilms contained eDNA organized into a mesh-like lattice that confers stability to the biofilm. 24 The complex organization of the EPS indicates that each component is essential to biofilm survival. DNABII family proteins have also been exhibited as a critical component to biofilm structural stability. [19] [20] [21] 33 Integration host factor, a member of the DNABII family proteins, binds extracellular DNA within the EPS of bacterial biofilms. Exposure of biofilms to antibodies directed against IHF was notable for its ability to significantly disrupt the EPS, resulting in catastrophic collapse of the biofilm with release of the resident bacteria that were highly susceptible to the killing action of traditional antibiotics. 22 For this reason, antibodies directed against IHF might serve as a novel therapeutic to disrupt those biofilms responsible for chronic otorrhea, thus rendering them susceptible to antibiotic regimens. The synergistic effect of anti-IHF and topical antibiotic therapy would likely mediate a more effective clearance of bacterial biofilms from the middle ear space and tympanostomy tubes to decrease the incidence and chronicity of otorrhea.
Our study demonstrated that the majority of posttympanostomy tube otorrhea specimens contained fragments of biofilms, which included an extensive lattice of eDNA with integrated DNABII protein (e.g., IHF) within the biofilm matrix. This study is the first to examine chronic otorrhea specimens for the presence of a bacterial biofilm with specific structural elements. We also demonstrated that a majority of culture-positive samples were also positive for the presence of IHF.
CONCLUSION
Post-tympanostomy tube otorrhea is a common pathological consequence that affects a high percentage of children. Sixty percent of specimens obtained in this study suggested the presence of biofilms through the positive labeling of both eDNA and IHF in the solid fragments within otorrhea samples. Our results suggest that biofilms may play an important role in the persistence of otorrhea after tympanostomy tube placement. Moreover, the presence of a DNABII protein responsible for biofilm structural integrity in the majority of these specimens provides an intriguing target for the development of a novel therapeutic that may be used at the bedside to improve quality of life and treatment of post-tympanostomy tube otorrhea. Fluorescent microscopy image of same otorrhea sample at 633 magnification: Section labeled for presence of integration host factor (red). Positive labeling (red) was observed at a majority of the vertices (blue arrows) formed by crossed strands of eDNA (pseudocolored white).
eDNA 5 extracellular DNA.
